RYAN FROST: Open Payments
NPI 1629472105 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,995 in 97 payments from 10 companies in 2025. Trend: 2023 $1,151 · 2024 $2,287 · 2025 $1,995
Food & beverage: $1,995
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 58 | $992 |
| Gilead Sciences, Inc. | 18 | $513 |
| ABBVIE INC. | 5 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $88 |
| Lilly USA, LLC | 3 | $83 |
| EMD Serono, Inc. | 4 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Napo Pharmaceuticals Inc | 1 | $24 |
Products named: DOVATO, APRETUDE, CABENUVA, VRAYLAR, Biktarvy, CAPLYTA, MOUNJARO, INGREZZA.
Industry payments across CA — which companies pay providers there.
